diagnosed in any patient in whom a tumoui had been demonstrated, together with a plasma potassium of less than 3 mEq/l. and a bicarbonate greater than 30 mEq/I. prior to therapy, hyperglycxmia, and plasma cortisol of more than 40 ,ig/I00 ml with no nyctohemeral rhythm. Tissue was extracted by the method of Lyons (1937) and assayed by biological (Lipscomb & Nelson 1962) and radioimmunological methods, using two antiseraone reacting with a sequence within the biologically active N-terminal 24 amino acids, and the other reacting with the biologically inactive C-terminal part (amino acids 25-39). ACTH levels found in tumours associated with the ectopic ACTH syndrome are shown in Bronchial carcinoids associated with the syndrome are clearly distinguished from 'controls' by their high values (> 1 ,ug/g) but there is no clear distinction between most oat cell ectopics and the 'control' tumour levels. The significance of the biological and immunological ACTH activity in the 'control' tumours is not clear but is unlikely to be due to sequestered blood. These tumours may be synthesizing ACTH but not releasing it at a rate sufficient to produce clinical evidence of metabolic disturbance. Other data are consistent with these findings (Liddle et al. 1969 ) and are compatible with this hypothesis (Werk et al. 1963) . It is of interest, but so far unexplained, that the ratio of Cto N-terminal tumour immunoactivity is much greater in the ectopic ACTH syndrome due to bronchial carcinoids than in that due to oat cell carcinoma of the bronchus. Much current work on the long-acting thyroid stimulator (LATS) is based on the ability of thyroid extracts to bind LATS. The absorbing or binding property of thyroid extracts is attributed to LATS-absorbing activity (LAA). It is hoped that purification of LAA may reveal the antigen to which LATS may be an antibody.
Absorption of LATS is usually demonstrated by comparing the responses to potent LATS sera with similar aliquots which have been incubated with thyroid extracts. When the commonly used McKenzie (1958) procedure is employed, LATS absorption is thus demonstrated (by the decline in LATS response) in mice which have been injected with a mixture of LATS and thyroid fractions containing LAA. Recently Florsheim et al. (1970) have shown that variations in the quantities of thyroxine administered or the injection of thyroglobulin-rich thyroid fractions in mice prepared for the McKenzie assay may inhibit the LATS response. They suggest that a critical evaluation of experiments claiming to demonstrate absorption of LATS is needed.
There are several lines of evidence which suggest that LATS is bound to LAA and that LATS absorption does truly occur:
(1) LAA can be isolated with a small proportion of the total thyroid protein in a 4S fraction which 'Present address: Department of Biochemistry, University of Toronto, Toronto 5, Ontario, Canada 54 is not related to fully formed t.hyroglobulin (Smith 1970 ).
(2) After absorption, LATS activity can be dissociated from LAA by exposure to 2M NaSCN.
(3) Absorption can be demonstrated in the assay in vitro of Brown & Munro (1967) . The potency of LAA assayed in vitro parallels the effects in the McKenzie assay in vivo.
(4) LAA is unstable to heat (56°C for 1 h) but the complex formed between LATS and LAA is stable; (5) The injection of LAA into mice pretreated with potent LATS sera removes thyroid stimulating activity from their circulating blood. (6) LAA can be conjugated to sepharose and the time course of interaction between LATS and LAA studied at selected intervals by centrifugation of conjugated LAA to which LATS has become bound. Assay of the supernatant for loss of LATS activity allows the rate of binding of LATS to LAA to be defined (Smith 1971 Long-acting thyroid-stimulating (LATS) activity is found in the immunoglobulin IgG isolated from sera of some thyrotoxic patients. In addition to its effects on the thyroid, LATS has been shown to have a stimulatory effect on the adrenal cortex of mice (El Kabir & Hockaday 1969 ) and on the release of luteinizing hormone (LH) from the rat pituitary (El Kabir et A-A no additions. o----o LATS-negative entered the mouse thyroid follicular cells but not in its absence (El Kabir et al. 1968 ). This observation suggested that one of the effects of LATS could be an alteration in the permeability of the cell membrane. Studies on changes in membrane permeability due to LATS were extended to the bacterium Escherichia coli. The genetics of the Lac operon of E. coli (whose products are involved in the transport and utilization of lactose) is now well understood (Jacob & Monod 1961). In the presence of lactose or a gratuitous inducer such as isopropylthio-p-D-galactoside (IPTG) the enzyme fB-galactosidase and a specific permease and acetylase are synthesized under the direction of the lac-z, lac-y and lac-a genes respectively. E. coli strain 200U (isolated by Professor J R Beckwith) carries a deletion of the lac-y gene. A consequence of this deletion is that the lac operon cannot be induced with low concentrations of inducer (O14M IPTG) but enzyme synthesis can take place with 1O-3M IPTG, not through active transport but due to diffusion of the inducer into the cell.
The results (Fig 1) show that, in the presence of low concentrations of inducer, P-galactosidase cannot be synthesized and that the presence of the pituitary thyroid-stimulating hormone (TSH) in the culture medium, or of LATSnegative IgG preparations, did not effect the system although induction with 10-M-IPTG was possible as usual. The presence of LATSpositive IgG allowed enzyme synthesis even with low concentrations of inducer, suggesting an alteration in membrane permeability.
